MedPath

浙江沣华医药科技有限公司

Ownership
-
Established
2021-09-29
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Lidocaine and Prilocaine Cream

Product Name
利丙双卡因乳膏
Approval Number
国药准字H20253758
Approval Date
Apr 1, 2025
NMPA

Phloroglucinol Orally Disintegrating Tablets

Product Name
间苯三酚口崩片
Approval Number
国药准字H20253277
Approval Date
Jan 24, 2025
NMPA

Calcium gluconate Injection

Product Name
葡萄糖酸钙注射液
Approval Number
国药准字H20253183
Approval Date
Jan 14, 2025
NMPA

Dobutamine Hydrochloride Injection

Product Name
盐酸多巴酚丁胺注射液
Approval Number
国药准字H20249223
Approval Date
Oct 29, 2024
NMPA

芩芷鼻炎糖浆

Approval Number
国药准字Z20194016
Approval Date
Apr 1, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.